Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,515 | 89,789 | 97,648 | 129,440 | 154,868 |
| Marketable Securities | 4,647 | 7,907 | 21,359 | 24,186 | 499 |
| Receivables | 19,365 | 15,268 | 12,954 | 13,846 | 32,285 |
| Other current assets | 29,839 | 30,847 | 8,311 | 7,695 | 7,523 |
| TOTAL | $137,366 | $143,811 | $140,272 | $175,167 | $195,175 |
| Non-Current Assets | |||||
| PPE Net | 61,708 | 63,621 | 70,759 | 73,953 | 76,523 |
| Intangibles | 713 | 718 | 1,511 | 1,584 | 1,698 |
| Other Non-Current Assets | 51,621 | 53,066 | 67,038 | 70,179 | 73,794 |
| TOTAL | $114,042 | $117,405 | $139,308 | $145,716 | $152,015 |
| Total Assets | $251,408 | $261,216 | $279,580 | $320,883 | $347,191 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,188 | 5,088 | 10,379 | 11,310 | 12,607 |
| Accounts payable and accrued liabilities | 22,324 | 21,456 | 22,353 | 24,159 | 20,921 |
| Other current liabilities | 7,105 | 13,656 | 12,007 | 11,324 | 9,820 |
| TOTAL | $60,468 | $62,995 | $53,030 | $55,282 | $52,337 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,625 | 20,531 | 14,699 | 15,636 | 18,345 |
| Deferred Revenues | 342 | 59 | 320 | 400 | 581 |
| Other Non-Current Liabilities | 53,275 | 53,492 | 69,036 | 69,949 | 76,301 |
| TOTAL | $70,450 | $72,279 | $80,937 | $85,079 | $91,800 |
| Total Liabilities | $130,918 | $135,275 | $133,967 | $140,361 | $144,137 |
| Shareholders' Equity | |||||
| Common Shares | 3,487 | 2,955 | 2,949 | 2,946 | 2,945 |
| Retained earnings | -469,294 | -439,504 | -409,921 | -371,670 | -727,973 |
| Other shareholders' equity | -21,790 | -20,632 | -26,463 | -18,038 | -9,251 |
| TOTAL | $120,489 | $125,941 | $145,612 | $180,522 | $203,054 |
| Total Liabilities And Equity | $251,407 | $261,216 | $279,579 | $320,883 | $347,191 |